Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
   S01 OPHTHALMOLOGICALS
     S01A ANTIINFECTIVES
     S01B ANTIINFLAMMATORY AGENTS
     S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
     S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
     S01F MYDRIATICS AND CYCLOPLEGICS
     S01G DECONGESTANTS AND ANTIALLERGICS
     S01H LOCAL ANESTHETICS
     S01J DIAGNOSTIC AGENTS
     S01K SURGICAL AIDS
     S01L OCULAR VASCULAR DISORDER AGENTS
       S01LA Antineovascularisation agents
         S01LA01 Verteporfin
         S01LA02 Anecortave
         S01LA03 Pegaptanib
         S01LA04 Ranibizumab
         S01LA05 Aflibercept
           D09574  Aflibercept (USAN/INN) <JP/US>
         S01LA06 Brolucizumab
     S01X OTHER OPHTHALMOLOGICALS
   S02 OTOLOGICALS
   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 6, 2019
According to WHO's ATC 2020

» Japanese version